Cipla Targets Global Respiratory Biosimilars With Kemwell JV
Indian Firm Will Bring Its ‘Respiratory Prowess’ To Planned Venture
Cipla is to establish a new company with CDMO Kemwell Biopharma to develop and launch biosimilars for the global market, especially in the respiratory space, where Cipla has built a considerable presence for inhalation products.
